v3.26.1
Stockholders' Equity (Tables)
 6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Summary of Stock Option Activity and Weighted Average Exercise Prices
The following table is a summary of the Company’s stock option activity and weighted average exercise prices for the six months ended June 30, 2026:
Stock Option ActivityWeighted Average Remaining Contractual Term
(In years)		Aggregate Intrinsic Value
(In thousands)
Options
(In thousands)		Weighted
Average
Exercise Price
Balance outstanding at December 31, 2025178 $184.30 5.92$— 
Cancelled or expired(6)321.40 
Balance outstanding at June 30, 2026172 179.83 5.59— 
Options vested and expected to vest 99 302.36 3.91— 
Options exercisable at June 30, 202679 $373.58 2.60$— 
The total fair value of stock options exercised during the six months ended June 30, 2026 and 2025 was immaterial.
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity
The following table is a summary of the Company’s RSU and PRSU activity and weighted average grant date fair value for the six months ended June 30, 2026:
Number of Shares
Weighted Average Grant Date Fair Value
Aggregate Fair Value
(In thousands)(Per share)(In thousands)
Balance outstanding at December 31, 2025783 $15.45 $3,028 
Awarded44 3.76 
Vested(204)18.32 
Forfeited(24)21.50 
Non-vested and outstanding at June 30, 2026599 13.38 1,137 
Expected to vest 523 $13.69 $994 
Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award
Total stock-based compensation costs included in the condensed consolidated statements of operations for the three and six months ended June 30, 2026 and 2025 are as follows:
Three Months Ended June 30,Six Months Ended June 30,
2026202520262025
(In thousands)(In thousands)
Cost of revenue $55 $203 $136 $389 
Sales and marketing 577 1,059 1,084 2,437 
General and administrative 1,285 1,755 2,438 3,528 
Product development 420 1,243 941 2,615 
Total$2,337 $4,260 $4,599 $8,969